RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 30 DOSES + BAND
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010702990021 -
GGREM
510614060052002 -
Código de barras
7896015528829
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- TRIFENATATO DE VILANTEROL;FUROATO DE FLUTICASONA
- Embalagem
- 100 MCG + 25 MCG PÓ INAL OR CT STR X 30 DOSES + BAND
- Tipo de produto
- Novo
- Classe terapêutica
- R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES
Nomes pelos quais este registro é encontrado
- RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 30 DOSES + BAND
- RELVAR ELLIPTA
- TRIFENATATO DE VILANTEROL
- FUROATO DE FLUTICASONA
Dados completos da fonte
{
"name": "RELVAR ELLIPTA 100 MCG + 25 MCG PÓ INAL OR CT STR X 30 DOSES + BAND",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": null,
"barcodes": [
"7896015528829"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510614060052002",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "RELVAR ELLIPTA",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "100 MCG + 25 MCG PÓ INAL OR CT STR X 30 DOSES + BAND",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "130.47",
"icms-12": "148.26",
"icms-17": "157.19",
"icms-18": "159.11",
"icms-19": "161.07",
"icms-20": "163.09",
"icms-21": "165.15",
"icms-22": "167.27",
"icms-23": "169.44",
"icms-17.5": "158.15",
"icms-19.5": "162.07",
"icms-20.5": "164.11",
"icms-22.5": "168.35",
"icms-12-alc": "132.38",
"icms-17-alc": "140.35",
"icms-18-alc": "142.06",
"icms-19-alc": "143.82",
"icms-20-alc": "145.61",
"icms-21-alc": "147.46",
"icms-22-alc": "149.35",
"icms-23-alc": "151.29",
"withoutTaxes": "116.49",
"icms-17.5-alc": "141.20",
"icms-19.5-alc": "144.71",
"icms-20.5-alc": "146.53",
"icms-22.5-alc": "150.31"
},
"pisCofinsList": "Negativa",
"substanceText": "TRIFENATATO DE VILANTEROL;FUROATO DE FLUTICASONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "175.02",
"icms-12": "198.89",
"icms-17": "210.86",
"icms-18": "213.44",
"icms-19": "216.07",
"icms-20": "218.78",
"icms-21": "221.54",
"icms-22": "224.39",
"icms-23": "227.30",
"icms-17.5": "212.15",
"icms-19.5": "217.41",
"icms-20.5": "220.15",
"icms-22.5": "225.84",
"icms-12-alc": "183.01",
"icms-17-alc": "194.03",
"icms-18-alc": "196.39",
"icms-19-alc": "198.82",
"icms-20-alc": "201.30",
"icms-21-alc": "203.85",
"icms-22-alc": "206.47",
"icms-23-alc": "209.15",
"withoutTaxes": "161.04",
"icms-17.5-alc": "195.20",
"icms-19.5-alc": "200.05",
"icms-20.5-alc": "202.57",
"icms-22.5-alc": "207.79"
},
"invalidBarcodes": [],
"activeSubstances": [
"TRIFENATATO DE VILANTEROL",
"FUROATO DE FLUTICASONA"
],
"therapeuticClass": "R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010702990021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "R3F1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510614060052002"